Rating History for ARS Pharmaceuticals Inc (SPRY) by Northland
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/9/2026 | Carl Byrnes Jr. | New Coverage | Outperform (N/A) |
25.00 (N/A) |
8.19 (9.98) |
21.86% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/9/2026 | Carl Byrnes Jr. | New Coverage | Outperform (N/A) |
25.00 (N/A) |
8.19 (9.98) |
21.86% | Details |